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Usher syndrome type I is an autosomal recessive disorder marked by hearing loss, vestibular areflexia, and retinitis
pigmentosa. Six Usher I genetic subtypes at loci USH1A–USH1F have been reported. TheMYO7A gene is responsible
for USH1B, the most common subtype. In our analysis, 151 families with Usher I were screened by linkage and
mutation analysis. MYO7A mutations were identified in 64 families with Usher I. Of the remaining 87 families,
who were negative for MYO7A mutations, 54 were informative for linkage analysis and were screened with the
remaining USH1 loci markers. Results of linkage and heterogeneity analyses showed no evidence of Usher types
Ia or Ie. However, one maximum LOD score was observed lying within the USH1D region. Two lesser peak LOD
scores were observed outside and between the putative regions for USH1D and USH1F, on chromosome 10. A
HOMOG plot shows evidence of heterogeneity across the USH1D, USH1F, and intervening regions. These2x(1)
results provide conclusive evidence that the second-most-common subtype of Usher I is due to genes on chromosome
10, and they confirm the existence of one Usher I gene in the previously defined USH1D region, as well as providing
evidence for a second, and possibly a third, gene in the 10p/q region.
Usher syndrome is defined as congenital neurosensory
hearing loss with retinitis pigmentosa (RP). Its frequency
is estimated to be 3.5/100,000 in Scandinavia (Hallgren
1959; Nuutila 1970; Grondahl 1987) and 4.4/100,000
in the United States (Boughman et al. 1983). Although
relatively rare, Usher syndrome has been estimated to
account for 50% of all individuals who are both deaf
and blind and for ∼3%–6% of all children who are deaf
(Vernon 1969).
Usher syndrome is both clinically and genetically het-
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erogeneous. Clinical heterogeneity is demonstrated by
the variation in the severity and progression of the hear-
ing impairment, the age at onset of retinal degeneration,
and the presence or absence of vestibular areflexia. There
are three clinical types of Usher syndrome. Usher type
I is the most severe subtype, characterized by congenital
profound deafness, early-onset RP (usually diagnosed
before puberty), and absent or severely diminished ves-
tibular responses. Usher type II is marked by a congenital
moderate-to-severe hearing impairment that is identified
by a characteristic sloping audiogram, a later diagnosis
of RP (during the 2d decade of life), and normal vestib-
ular responses. Usher type III is characterized by a pro-
gressive hearing loss, with variable RP and progressive
vestibular dysfunction (Kimberling and Moller 1995;
Smith et al. 1995). Types I and II are the most common
forms of Usher syndrome.
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Table 1
Summary of the Clinical and Genetic Subtypes of the Usher Syndromes
Usher Typea and Location Gene Screening Markersb
I
USH1A-14q32 D14S78, D14S250, D14S292, D14S260
USH1B-11q13.5 MYO7A D11S527, D11S4186, D11S906, D11S911
USH1C-11p15.1 USH1C D11S921, D11S902, D11S4160, D11S899
USH1D-10q21-22 D10S529, D10S195, D10S202, D10S573
USH1E-21q21 D21S1905, D21S1914, D21S269, D21S1913
USH1F-10 D10S193, D10S1791, D10S220, D10S1790
II
USH2A-1q41c USH2A D1S237, AFM143, AFM144, D1S490
USH2B-3p
USH-5qc D5S617, D5S484, D5S505, D5S485
III
USH3-3q21-25 D3S1555, D3S1308, D3S1279, D3S1280
a Phenotypes are described in the text.
b Markers typed for linkage analysis in the present study.
c Families were tested for linkage for Usher II and III markers. The results were negative and are
not reported here.
Table 2
Distribution of MYO7A Mutations in 169 Families with Usher
Syndrome
Usher
Phenotype(s) Mutation
Linkage
Informative? No.
I MYO7A Yes 46
I MYO7A No 18
I MYO7A Yes 54
I MYO7A No 33
II and III MYO7A No 18
Total 169
NOTE.—Families are divided by phenotype, the presence or absence
of at least one pathologic MYO7A mutation, and informativeness.
MYO7A represents 64 families with Usher I with at least one iden-
tifiable MYO7A mutation; only 46 of these families are informative
for linkage. The remaining families revealed no mutation (MYO7A).
The analysis reported here has focused on the 54 MYO7A families
with Usher I that were informative for linkage analysis.
At least 10 loci have been identified for Usher syn-
drome: 6 for Usher type I (USH1A–USH1F), 3 for Usher
type II (USH2A–USH2C) and 1 for Usher type III (Kim-
berling et al. 1990, 1992; Kaplan et al. 1992; Smith et
al. 1992; Sankila et al. 1995; Wayne et al. 1996, 1997;
Chaib et al. 1997; Hmani et al. 1999; Pieke-Dahl et al.
2000) (table 1). The most common form of Usher type
I, Ib, is localized to 11q13.5 (locus USH1B [MIM
276903]). The other five loci are believed to be uncom-
mon: the gene for Usher type Ia maps to 14q32 and has
been observed in families with ancestry from the Poitou-
Charentes region of France (Kaplan et al. 1992); type
Ic maps to 11p15.1 and has been reported in the French
Acadian population (Smith et al. 1992); type Ie has been
mapped to 21q21 by homozygosity mapping in a Mor-
occan family (Chaib et al. 1997); and types Id and If
both map to chromosome 10 and have been identified
in single Pakistani (Id) and Hutterite (If) families, re-
spectively (Wayne et al. 1996, 1997). Usher syndrome
type II is known to have at least three loci, and there is
evidence for an additional, as yet unlocalized, subtype
(Pieke-Dahl et al. 2000). Usher type IIa is the most com-
mon of the milder forms of Usher syndrome and maps
to 1q41 (Kimberling et al. 1990). Type IIb maps to chro-
mosome 3p23-24.2 (Hmani et al. 1999), and Usher type
IIc maps to 5q14.3-21.3 (Pieke-Dahl et al. 2000). There
is only one Usher III locus, USH3, mapping to 3q21-25
(Sankila et al. 1995). Families reported to have Usher
type III are primarily of Finnish origin; however, there
are reports of one Italian family (Gasparini et al. 1998)
and two Spanish families that showed linkage to the 3q
region (Espinos et al. 1998).
For the 10 known Usher loci, 3 genes have been iden-
tified. MYO7A is responsible for Usher Ib; USH2A is a
novel gene, responsible for Usher IIa, that codes for a
protein now called “usherin”; and the third gene,
USH1C, which codes for a PDZ (PSD95, Dlg, ZO-1)
domain–containing protein named “harmonin,” has
been recently identified (Verpy et al. 2000; Bitner-Glind-
zicz et al. 2000). Mutations inMYO7A have been found
to account for ∼60% of all Usher I cases (W.J.K., un-
published data). Although a wide spectrum of mutations
in theMYO7A gene have been described in patients with
Usher Ib, the gene has also been shown to harbor mu-
tations producing nonsyndromic deafness, including
DFNA11 and DFNB2, as well as atypical Usher syn-
drome with progressive hearing loss (Levy et al. 1997;
Liu et al. 1997a, 1997b, 1998).
Here we report the results of linkage and mutation
analysis of 169 families with Usher that represent diverse
backgrounds from the United States, Europe, Colombia,
and South Africa. Our results show that one or more
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Table 3
Summary of Heterogeneity Analysis of 54 Families with Usher
Type I
Usher
Subtype
Marker
Set a Heterogeneity x2
IA 14q .05 .11
IB 11q .15 3.98a
IC 11p .15 4.15a
ID/IF 10 .75 36.30a
IE 21q .05 .81
NOTE.—Heterogeneity analysis was performed with the HOMOG
program using markers spanning each of the USHI loci.
a Significant, providing evidence for presence of subtypes.
Table 4
Results of Two-Point Analysis, on Chromosome 10, for 54
Families with Usher Type I
MARKER
TWO-POINT LOD SCORE AT v p
0 .05 .1 .2 .3 .4
D10S193  8.648 3.316 .019 .527 .264
D10S1791  3.962 .213 1.487 1.130 .411
D10S220  4.106 .375 1.378 .999 .278
D10S1784  .147 .120 .072 .033 .009
D10S1790  3.245 .099 1.545 1.027 .240
D10S1756  .652 .680 1.115 .723 .240
D10S1743  3.097 4.210 3.517 1.918 .560
D10S1665  .669 2.219 2.106 1.136 .259
D10S529  3.970 5.268a 4.297 2.339 .629
D10S195  1.859 4.219 4.175 2.494 .802
D10S202  1.050 3.142 3.198 1.916 .621
D10S573  3.035 .261 1.658 1.138 .338
a Highest two-point LOD score.
genes on chromosome 10 are responsible for a majority
of the families with Usher I that is not linked toMYO7A
(MYO7A).
We studied 169 independent families, including 242
affected individuals, with Usher syndrome. Of these fam-
ilies, 151 had Usher I, 12 had Usher II, and 6 had Usher
III (table 2). The results for Usher types II and III will
be reported elsewhere. Sixteen families with Usher I were
consanguineous. The families were collected in the
United States (86 families), The Netherlands (37 fami-
lies), Sweden (31 families), South Africa (5 families),
Spain (4 families), Colombia (3 families), and England
(3 families); however, the ethnic composition is primarily
of European extraction. The five South African and three
Colombian families were of European ancestry. The
sample group also included two French Acadian families
who showed linkage to the USH1C region.
All families were assigned to a specific subtype of
Usher syndrome on the basis of the pattern and severity
of hearing loss, the presence or absence of vestibular
areflexia, and the presence of RP. The clinical diagnosis
was determined from the patient’s medical history and
results of audiometric, ophthalmologic, and vestibular
examinations. The human-subjects committee at each
location approved this study, and written, informed con-
sent was obtained from all participants.
Blood samples were collected, and genomic DNA was
extracted using a Puregene kit (Gentra Systems). Fluo-
rescent (6-FAM, TET, or HEX) oligonucleotide primers
were used to amplify polymorphic markers surrounding
the various Usher loci (for the specific markers that were
typed, see table 1). Markers were amplified according
to the following protocol: 95C for 5 min, 30 cycles
(94C for 1 min, 60C for 1 min, and 72C for 1 min)
and 60C for 30 min. PCR products were then pooled,
denatured, and separated on 4.25% polyacrylamide gels
in an ABI 377 automated sequencer (PE Biosystems),
and fragment analysis was performed using GENE-
SCAN 2.1 software. Genotyping data were collected and
were analyzed using GENOTYPER 2.0.
All families with Usher I in the present report had
been subjects of a previous report on a mutation screen
of 14 exons (Weston et al. 1996). However, themutation
analysis in the present report involved screening 46 of
the 48 coding exons for all 169 families in our sample.
A summary of the mutations observed is available on
the GeneClinics home page, and a report on these mu-
tations will be published elsewhere.
Linkage analysis of DNA markers was performed us-
ing the LINKAGE programs (Lathrop et al. 1985). Two-
point and multipoint analyses were computed for all 54
families with MYO7A Usher syndrome. Rolling mul-
tipoint analysis across the entire span of chromosome
10 markers generated LOD scores by comparison of
overlapping sets of four contiguous marker loci with
the test locus (five-point analysis). The pattern of in-
heritance of Usher syndromewas assumed to be recessive
with full penetrance for the mutant homozygote. Gene
frequency of the mutant allele was set at .001. The num-
ber of alleles was taken from information in the White-
head Institute for Biomedical Research/MIT Center for
Genome Research home page and the The Genome Da-
tabase home page. The frequencies of the marker alleles
were assumed to be equal. Heterogeneity analysis was
done using the rolling multipoint LOD scores, generated
as outlined above, with HOMOG, version 2.4.
Of the 169 families initially studied, 151 had Usher
type I. Of the families with Usher I, 64 had at least one
detectable MYO7A mutation. Of the families with
MYO7A Usher I, 54 were informative for linkage and
were analyzed using the LINKAGE and HOMOG com-
puter programs. These 54 families were screened with
flanking markers, as summarized in table 1, for all
known USH1 loci. Both two-point and rolling multi-
point analyses were performed on all families, using all
USH1 loci. Except for chromosome 10 markers, none
of the LOD scores were significantly positive—that is,
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Figure 1 Map of chromosome 10. The critical regions of
USH1D and USH1F are outlined, and the markers used in the linkage
analysis are listed, with their position (in cM) from the p-arm telomere.
Figure 2 Map of multipoint LOD scores for chromosome 10
markers and the families with MYO7A Usher I: results of chromo-
some 10 multipoint analysis for all families, with the exclusion of the
three 11q-linked and two French Acadian families. A LOD score of
1.03 lies between markers D10S1743 and D10S1665 between the two
defined regions of USH1D and USH1F, and a LOD score of 2.89 lies
within the USH1D region. Additional LOD scores, of 1.60 and 3.77,
lie outside the regions of USH1F and USH1D, respectively.
there was no evidence for linkage outside chromosome
10. All sets of scores generated from the rolling multi-
point analysis were used for a multiple HOMOG anal-
ysis. Table 3 summarizes the results of the HOMOG
analyses for each Usher locus. The x2 values of 0.81 and
0.11 are clearly not significant, providing no evidence
for the presence of either USH1A or USH1E in this sam-
ple. However, the values of 3.98, 4.15, and 36.302x(1)
suggest the presence of a mixture of USH1B, USH1C,
USH1D, or USH1D/USH1F within the 54 families.
Two French Acadian families were included in the
MYO7A screening to test the possibility of a digenic
effect involving the MYO7A gene; however, no muta-
tions were detected. The sensitivity of the HOMOGpro-
gram is demonstrated by the detection of linkage het-
erogeneity as a result of the inclusion of these two
families. In addition, we identified three families that
each had LOD scores 12.0 for 11q markers. We be-
lieve that these families have MYO7A mutations that
were not detectable by our testing strategy. When these
five families were removed from the analysis, the sig-
nificant HOMOG values for USH1B and USH1C2x(1)
disappeared.
The highly significant value of 36.30 for chro-2x(1)
mosome 10 markers prompted us to further examine the
USH1D and USH1F regions. The USH1D and USH1F
loci have been mapped to chromosomal locations
10q21.22 and 10pq (fig. 1). The broad critical regions
and close proximity of these two loci to each other
necessitated the selection of 12 chromosome 10 markers
spanning both critical regions, as well as the intervening
space, covering a distance of ∼50 cM. These markers
were used in two-point and rolling multipoint analyses.
Table 4 shows the results of the two-point analysis for
the individual markers, for USHID/USH1F. The highest
LOD score, 5.27, was obtained for marker D10S529 at
.vp .10
Multipoint analysis of the non-USH1B families, with
the exclusion of the two families of French Acadian an-
cestry and of three families with 11q linkage, resulted
in one significant maximum LOD score (Zmax), 3.77,
lying on the qter side, just beyond the USH1D critical
region. In addition, a LOD of 1.03 was observed be-
tween markers D10S1743 and D10S1665, which is be-
tween the two previously defined critical regions of
USH1D and USH1F. In addition, a Zmax of 2.89 also lies
within the USH1D region. Interestingly, the analysis also
provided a LOD score of 1.60 just pter of the putative
region of USH1F (fig. 2). On the surface, these results
do not support the hypothesis of an Usher gene in the
USH1F region. However, the impact that heterogeneity
due to linked genes has on LOD scores is not well un-
derstood; and it is conceivable that a mixture of families
that are heterogeneous because of linked genes could
yield a LOD-score distribution with maxima that are
shifted from the true location of the genes actually re-
sponsible. We had expected to see bimodality in the het-
erogeneity but found only a single maximum cor-2x(1)
responding to the presence of an USH1D locus (fig. 3).
It may be that Usher If is not frequent and that there
are too few families in our sample for the second max-
imum to be detected. An alternative explanation is that
USH1F is incorrectly mapped and that it actually lies
between markers D10S1743 and D10S1665 or that
there is another Usher I gene lying between USH1D and
USH1F.
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Figure 3 Plot of chromosome 10 HOMOG analysis. Rolling
x2 values generated from the chromosome 10multipoint analyses (data
from fig. 2) are plotted against position (in cM). A maximum x2 of
40.44 lies in USH1D and a second, lesser x2 value of 28.71 lies just
outside the USH1F region.
These data provide an initial estimate of the propor-
tion of the various Usher type I subtypes. Our original
sample of 169 families with Usher syndrome was sub-
divided on the basis of the presence or absence of a
MYO7Amutation. After the exclusion of the 18 families
with Usher II and Usher III and of the 51 families with
non–linkage-informative Usher I, the remaining sample
consisted of 100 families with linkage-informative Usher
I (table 2). Forty-six families, representing 46% of the
group with linkage-informative Usher I, had a patho-
logicMYO7Amutation. The remaining 54 families with
Usher I did not have an identified mutation. These fam-
ilies represented 54% of our sample. From our analysis
of families with MYO7A Usher I, the proportion of
individuals with Usher type Ic in our sample is estimated
at 2%. The estimate for Usher Ic is obviously biased,
because the two families were purposefully included in
the analyses. In addition, the three families with Usher
1b linked to 11q constitute ∼3% of the sample. Thus,
in our sample, 49% of families with Usher I had a pre-
dicted or confirmed MYO7A mutation (i.e., Usher Ib).
Of the remaining families, 33 lacking the MYO7A link
to the USH1D and USH1F regions constitute 61% of
the MYO7A sample, or 33% of all families with link-
age-informative Usher I. The remaining individuals with
Usher I are unconfirmed for linkage to any of the six
Usher I loci, and they constitute 16% of the sample.
The findings presented here have important implica-
tions for characterizing and defining the heterogeneity
of Usher syndrome type I. These results support the ge-
netic heterogeneity of Usher syndrome and also indicate
for the first time that USH1D/USH1F is the second-most-
common Usher I subtype.
The genetic heterogeneity of Usher syndrome type I
is complex and raises the question of clinical differen-
tiation. Our clinical findings have not yet suggested any
obvious clinical variance between these subgroups.
However, deeper and more-extensive examinations of
the audiologic, vestibular, and retinal phenotypes may
reveal differences that, because of heterogeneity, had not
previously been noticed. Consequently, our next efforts
will focus on the use of both clinical and genetic factors
to differentiate, characterize, and further define the het-
erogeneity of the Usher I subtypes.
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